Prime Medicine Inc [PRME]
Pivot duomenys
Pivot statistika
| Rodiklis | Vidurkis | Mediana | Stand. nuokr. |
|---|---|---|---|
| Prieaugis % | 25.33% | 25.33% | 8.69% |
| Nuostolis % | -27.74% | -27.74% | 5.77% |
| Trukmė | 14.3d | 11d | 8.7d |
| Rasta pivot taškų | 5 |
| Prieaugio/nuostolio atkarpos | 4 (2 Prieaugis / 2 Nuostolis) |
| Paskutinis pivot | Top @ $3.23 data 2026-06-18 |
| Pokytis nuo paskutinio pivot | $0.00 (0.00%) |
Kito pivot prognozė Paskutinė: $0.00
| Prognozuojamas kitas tipas | Bottom |
| Prognozuojama kaina (vid.) | $2.33 |
| Prognozuojama kaina (mediana) | $2.33 |
| Prognozuojamas kainos intervalas (~68%) | $2.15 - $2.52 |
| Pokytis iki vidutinio tikslo | $2.33 (N/A) |
| Prognozuojama data (vid.) | 2026-07-02 |
| Prognozuojamas datos intervalas (~68%) | 2026-06-23 - 2026-07-10 |
| Pagrindas | Based on 2 historical losses (Avg: -27.74%, Median: -27.74%, StdDev of Abs: 5.77%) and duration (Avg: 14.2 days, StdDev: 8.7 days) |
| Pastaba | Ranges assume ~normal distribution & historical patterns repeat. Use with caution. |
Moderate gain for Prime Medicine Incon Thursday .
Prime Medicine Inc (PRME) stock price experienced a significant rise on Thursday after the stock rose $0.0700 (2.22%) from the previous session on normal volume. The stock slightly outperformed the market today, moving slightly ahead of the NASDAQ's 1.91% rise. A total of 3.50M stocks were traded yesterday, valued at $11.31M, 709 702 shares less than the previous day (4 211 334 shares traded). This is near the average volume for the stock at 2.92M shares traded per day.
Prime Medicine Inc signals
There is no conclusive signals given from RSI. The price is below both moving averages, and the short-term average is below the long-term average, confirming a sustained down-trend. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (-16.7%), medium- (-16.7%), and long-term (-16.7%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.
Prime Medicine Inc Support & Resistance Levels
The stock is approaching the closest resistance level at $3.24. approximately $0.0100 (0.31%) away. Pushing up towards resistance. Breaking above this level could signal further upside where next resistance level will be found at $3.64. On a fall back there will be support at $3.12 The dis das resistance s13.12 -
Prime Medicine Inc Evaluation
- Trumpas balas: -1.22
- Vidutinis balas: -2.21
- Ilgas balas: -2.64